Company profile: TKL Research
1.1 - Company Overview
Company description
- Provider of a fully integrated network of clinical research centers serving pharmaceutical, biotechnology, medical device, and consumer healthcare industries, offering inpatient and outpatient capabilities, including two purpose-built phase I clinical pharmacology units and five outpatient clinics equipped for phase II–IV clinical trials.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TKL Research
Accel Research Sites
HQ: United States
Website
- Description: Provider of multi-therapeutic clinical research services, conducting clinical trials across various medical conditions; centralized recruitment; project management for study startup and performance to ensure streamlined processes and quality assurance across sites; and Phase 1 trial facilities, including inpatient trials with specialized capabilities in oncology and other areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accel Research Sites company profile →
Eurofins
HQ: Luxembourg
Website
- Description: Provider of analytical testing and support services across pharmaceutical, food, environmental, and consumer products industries, including clinical diagnostics (sample collection, testing, counseling), environmental testing of water, air, soil and waste, cosmetics and personal care compliance testing, E&E product safety and approvals, maritime pollution and fuel/oil testing, and microbiological testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurofins company profile →
Perigord
HQ: Ireland
Website
- Description: Provider of best-in-class labeling artwork to life science companies, with unparalleled expertise in highly regulated sectors, and developer of the world’s only dedicated Pharmaceutical Artwork Management System, GLAMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perigord company profile →
IPA
HQ: Canada
Website
- Description: Provider of bioplatform-based, AI-driven antibody discovery and development services leveraging systems biology and multi-omics modeling. Offerings include target analysis and immunization, antibody discovery and characterization (sequencing and custom assays), developability profiling, and optimization/engineering (humanization, affinity maturation, chimerization). Includes LENSai Integrated Intelligence Technology for drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IPA company profile →
Continuus Pharmaceuticals
HQ: United States
Website
- Description: Provider of Build-Own-Operate integrated continuous manufacturing solutions for small molecule pharmaceuticals, designing, building, and running client-site processes. Offerings include end-to-end ICM pilot plants, continuous reactive crystallization, solvent recovery systems, EMC for oral solid dosage forms, and automated modular assembly lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Continuus Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TKL Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TKL Research
2.2 - Growth funds investing in similar companies to TKL Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TKL Research
4.2 - Public trading comparable groups for TKL Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →